Latest Stories
The Am Law 100, the Early Numbers: At Greenberg Traurig, Flat Revenue and a Dip in Profits
CEO Richard Rosenbaum attributes last year's fall-off in profits per partner and net income to an uptick in spending on new office openings, new computer technology, and other one-time expenses.Out of the Frying Pan And into the Dutch Oven
Tort reform may be all the rage on this side of the Atlantic. But across the pond, the litigation juggernaut is moving in just the opposite direction. This month, the Netherlands-America's ninth-largest trading partner and host to some 1,600 U.S. corporations-is set to move its system closer to U.S. law by permitting mass settlements. Add President Jacques Chirac's recent announcement that France might soon permit mass litigation, and what had been a leak in Europe's legal dike could become a dam-burst. U.SDLA Phillips Fox Sees Departures Ahead of International Merger
A group of lawyers led by partner Peter Tredinnick is leaving DLA Phillips Fox--DLA Piper's new Australian merger partner--in order to join Sydney's Moray & Agnew.Dewey Hit with WARN Suit as Partner Departures Suggest Merger Didn't Take
Dewey & LeBoeuf's days are numbered, as more partners defected Thursday for Baker Botts, Clifford Chance, Mayer Brown, Orrick, Patterson Belknap, and a spin-off boutique. Plus, the struggling firm found itself hit with its first WARN suit, and federal regulators moved to take over its underfunded pension plans.
The Am Law 100, the Early Numbers: Shearman Holds Revenue Steady, as Net Income Declines
Another year of mixed financial results saw Shearman & Sterling's gross revenues rise 0.3 percent in 2012, to $752 million, and its profits per partner fall 2.6 percent, to $1.52 million, according to The American Lawyer's reporting. Those figures notwithstanding, new senior partner Creighton Condon is upbeat when discussing the New York-based global firm's strategy going forward.S&C, Goodwin Lead on $10 Billion Amgen-Onyx Deal
Amgen, the world's largest biotechnology company, is set to add several anticancer drug treatments to its portfolio after agreeing to pay $10.4 billion to acquire Onyx Pharmaceuticals. Sullivan & Cromwell is advising Amgen, while Onyx has turned to Goodwin Procter.Bob Barnes Hits Back at Client Gone Wild in Court Filing
The legal divorce between Joe Francis of Girls Gone Wild fame and his soon-to-be-former lawyers from The Bernhoft Law Firm continues to remind us of a late-night infomercial.Trending Stories
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
More from ALM
Resources
The Power of Online Reputation Management For Attorneys: A Critical Tool For Law Firms in 2025
Brought to you by Erase.com
Download Now
The Role of Evolving Support Structures in Optimizing Legal Talent
Brought to you by BigHand
Download Now
AI-Powered Deposition and Medical Record Summaries: Low Risk, High Reward
Brought to you by Parrot
Download Now
Aligning Client Needs with Lawyer Growth and Profitability
Brought to you by BigHand
Download Now